Effects of Insulin on the Metabolic Control of Hepatic Gluconeogenesis In Vivo
Open Access
- 15 September 2009
- journal article
- Published by American Diabetes Association in Diabetes
- Vol. 58 (12), 2766-2775
- https://doi.org/10.2337/db09-0328
Abstract
OBJECTIVE: Insulin represses the expression of gluconeogenic genes at the mRNA level, but the hormone appears to have only weak inhibitory effects in vivo. The aims of this study were 1) to determine the maximal physiologic effect of insulin, 2) to determine the relative importance of its effects on gluconeogenic regulatory sites, and 3) to correlate those changes with alterations at the cellular level. RESEARCH DESIGN AND METHODS: Conscious 60-h fasted canines were studied at three insulin levels (near basal, 4×, or 16×) during a 5-h euglycemic clamp. Pancreatic hormones were controlled using somatostatin with portal insulin and glucagon infusions. Glucose metabolism was assessed using the arteriovenous difference technique, and molecular signals were assessed. RESULTS: Insulin reduced gluconeogenic flux to glucose-6-phosphate (G6P) but only at the near-maximal physiological level (16× basal). The effect was modest compared with its inhibitory effect on net hepatic glycogenolysis, occurred within 30 min, and was associated with a marked decrease in hepatic fat oxidation, increased liver fructose 2,6-bisphosphate level, and reductions in lactate, glycerol, and amino acid extraction. No further diminution in gluconeogenic flux to G6P occurred over the remaining 4.5 h of the study, despite a marked decrease in PEPCK content, suggesting poor control strength for this enzyme in gluconeogenic regulation in canines. CONCLUSIONS: Gluconeogenic flux can be rapidly inhibited by high insulin levels in canines. Initially decreased hepatic lactate extraction is important, and later reduced gluconeogenic precursor availability plays a role. Changes in PEPCK appear to have little or no acute effect on gluconeogenic flux.Keywords
This publication has 47 references indexed in Scilit:
- Fasting hyperglycemia is not associated with increased expression of PEPCK or G6Pc in patients with Type 2 DiabetesProceedings of the National Academy of Sciences, 2009
- Cytosolic Phosphoenolpyruvate Carboxykinase Does Not Solely Control the Rate of Hepatic Gluconeogenesis in the Intact Mouse LiverCell Metabolism, 2007
- Lactate release from adipose tissue and skeletal muscle in vivo: defective insulin regulation in insulin-resistant obese womenAmerican Journal of Physiology-Endocrinology and Metabolism, 2007
- Regulation of lipolysis in adipocytesAnnual Review of Nutrition, 2006
- Role of hepatic STAT3 in brain-insulin action on hepatic glucose productionCell Metabolism, 2006
- Hypothalamic KATP channels control hepatic glucose productionNature, 2005
- Effects of hyperglycemia on hepatic gluconeogenic flux during glycogen phosphorylase inhibition in the conscious dogAmerican Journal of Physiology-Endocrinology and Metabolism, 2004
- Mechanism by which glucose and insulin inhibit net hepatic glycogenolysis in humans.JCI Insight, 1998
- Hormonal regulation of amino acid transport system N in primary cultures of rat hepatocytesEuropean Journal of Biochemistry, 1987
- Inhibition of transcription of the phosphoenolpyruvate carboxykinase gene by insulinNature, 1983